<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007860.ref044">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Ong</surname>
   <given-names>EZ</given-names>
  </name>, 
  <name>
   <surname>Budigi</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Tan</surname>
   <given-names>HC</given-names>
  </name>, 
  <name>
   <surname>Robinson</surname>
   <given-names>LN</given-names>
  </name>, 
  <name>
   <surname>Rowley</surname>
   <given-names>KJ</given-names>
  </name>, 
  <name>
   <surname>Winnett</surname>
   <given-names>A</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Preclinical evaluation of VIS513, a therapeutic antibody against dengue virus, in non-human primates</article-title>. 
  <source>Antiviral research</source>. 
  <year>2017</year>;
  <volume>144</volume>:
  <fpage>44</fpage>â€“
  <lpage>7</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.05.007</pub-id> .
  <?supplied-pmid 28529000?>
  <pub-id pub-id-type="pmid">28529000</pub-id>
 </mixed-citation>
</ref>
